Altria’s stock extends fall as analyst warns against getting burned by buying the dip

Altria’s stock continued to sink on heavy volume in the wake of an FDA proposal on lowering nicotine levels, with RBC Capital warning investors not to buy the dip, like they might have done in the past.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.